ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. We are focused on improving the safety of oral therapies for chronic disease.

Making Safer Drugs

Despite rigorous pre-approval testing of all pharmaceutical products, many approved drugs have serious and life threatening side effects that go undiscovered until the products have been launched and are in widespread use. ARYx makes these known therapeutic mechanisms safer by engineering out specific metabolic problems that cause toxic and dangerous side effects. Our novel drug products are carefully constructed and optimized to alter and improve metabolism while maintaining established efficacy.

ARM Technology

By applying our innovative and integrated ARM (ARYx RetroMetabolic Drug Design™) technology, we now have three drug candidates in the clinic and substantial opportunities to continue to broaden our product pipeline.

Apply at ARYx

If you’re a highly motivated professional who welcomes creative challenges, we invite you to investigate career opportunities at ARYx.